Global Radiopharmaceuticals Market Research Report – 2025 Outlook, Trends, Share, Size & Forecast

MarkNtel Advisors has released an in-depth report on the Global Radiopharmaceuticals Market, offering critical insights into the market's size, growth, trend, projections, and emerging dynamics. This report delivers a comprehensive analysis of growth opportunities, competitive landscape, technological developments, and evolving consumer demands—equipping industry stakeholders with the data necessary to make informed decisions.

Get Free Sample Copy of the Report - https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html  

Global Radiopharmaceuticals Market Trend

Increasing Quest for New Radioisotopes & Radiopharmaceuticals – Driven by several limitations associated with the production of certain alpha-emitting isotopes, currently utilized in radiopharmaceuticals, the biopharma companies have begun to explore alternative radioisotopes, such as 211At, 223Radium, etc. For instance, in 2024, Novartis AG started a phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors. The newer radioisotopes tend to have intriguing opportunities for both imaging and therapy while potentially overcoming existing limitations. Further, coupled with an increase in cancer cases globally, the critical need to reduce the risks associated with conventional radiation therapy, has led to the exploration of newer radiopharmaceuticals. This, in turn, is expected to further drive the Global Radiopharmaceuticals Market during the forecasting years.

Leading Companies and Competitive Landscape of Global Radiopharmaceuticals Market

The competitive landscape of the Global Radiopharmaceuticals Market is shaped by both top giants and emerging players. These companies are actively involved in product launches, mergers & acquisitions, and geographical expansions to support their market presence.

Key Market Players Include:

• Bayer AG
• Iso-Tex Diagnostics, Inc.
• Jubilant Pharmova Limited
• Novartis AG
• General Electric Company
• Lantheus Holdings, Inc. 
• Eli Lilly and Company
• Siemens Healthineers AG
• Curium Pharma
• Cardinal Health
• Blue Earth Diagnostics, Inc. (Bracco Group)
• Acrotech Biopharm
• Northstar Medical Technologies LLC
• IBA Radiopharma Solutions 
• Sun Pharmaceutical Industries, Inc.
• Others

These players are continuously innovating and investing in technological solutions to meet the dynamic needs of the market while maintaining a competitive edge.

Full Report Summery [TOC + Content] - https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html  

Global Radiopharmaceuticals Market Segmentation and Region

 By Radioisotope

• Technetium 99
• Fluorine 18
• Iodine 131
• Gallium 68
• Iodine 123
• Others (Yttrium 90, Indium 111, etc.)

By Indication

• Oncology
• Cardiology
• Gastroenterology
• Nephrology
• Others (Neuroendocrinology, Neurology, etc.)

By Type

• Diagnostic
• Therapeutic

By End User

• Hospitals
• Medical Imaging Centers
• Others (Specialty Clinics, Research Organizations, etc.)

By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Frequently Asked Questions (FAQs)

1. What is the expected CAGR of the Global Radiopharmaceuticals Market during 2025-2030?
2. Which region holds the largest market share in the Global Radiopharmaceuticals Market?
3. Who are the leading players in the Global Radiopharmaceuticals Market?
4. What are the key trends driving the Global Radiopharmaceuticals Market forward?
5. What are the major challenges faced by new entrants in the market?

Fill the Form For Customized Report Enquiry - https://www.marknteladvisors.com/query/request-customization/radiopharmaceuticals-market.html  

Scope of the Report

• Provides an unbiased market forecast from 2025 to 2030
• Covers detailed company profiles and competitive analysis
• Includes segment-wise and region-wise market breakdown
• Offers insights into market drivers, challenges, and trends
• Equips stakeholders with data-backed strategic recommendations

About MarkNtel Advisors:

We are a leading market research firm providing research, consulting, and data-driven intelligence to clients across diverse industries globally. Our reports are tailored to help businesses identify lucrative opportunities and mitigate potential risks using actionable insights.

Contact Us:

MarkNtel Advisors LLP

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

For Sales Enquiries: sales@marknteladvisors.com